Sandoz Private Limited Clopidogrel Export Data — India (DGFT 2022–2026)

Name: Sandoz Private Limited Clopidogrel Export Records India — #9 Exporter, 105 Shipments, $5.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Clopidogrel

India Pharmaceutical Trade Intelligence

$251.3M416 Suppliers137 CountriesHS 30049099

ExportsIndia → UNITED STATES32.3%India → UNITED KINGDOM9.1%

ImportsFRANCE → India$1.7B ISRAEL → India$2.1M

#1 Buyer: NORTHSTAR DISTRIBUTION

Sandoz Private Limited — Clopidogrel Exporter #9 | $5.3M Trade Value | TransData Nexus | TransData Nexus

Sandoz Private Limited — Clopidogrel Exporter Profile

Indian Pharmaceutical Exporter · #9 for Clopidogrel · $5.3M export value · DGFT Verified

Sandoz Private Limited is the #9 Indian exporter of Clopidogrel with $5.3M in export value and 105 verified shipments. Sandoz Private Limited holds a 2.1% market share in Clopidogrel exports across 7 countries. The company exports 25 pharmaceutical products worth $159.4M across 15 therapeutic categories.

Sandoz Private Limited — Clopidogrel Export Profile: Buyers & Destinations

Sandoz Private Limited Clopidogrel export treemap — buyers and destination countries | TransData Nexus

Where Does Sandoz Private Limited Export Clopidogrel?

Country	Value	Shipments	Share
SLOVENIA	$1.9M	42	45.7%
CHINA	$908.4K	19	22.1%
TAIWAN	$816.6K	18	19.9%
THAILAND	$391.9K	12	9.6%
HONG KONG	$55.8K

Who Are the Top Buyers of Clopidogrel from Sandoz Private Limited?

Buyer	Country	Value	Orders
LEK D.D	SLOVENIA	$1.4M	32
SANDOZ(CHINA)PHARMACEUTICAL CO.,LTD	CHINA	$426.1K	9
LEK D D	SLOVENIA	$300.0K	6
NOVARTIS TAIWAN CO., LTD (SANDOZ)	TAIWAN	$283.0K	6
NOVARTIS (THAILAND) LIMITED	THAILAND	$257.7K	8
LEK D D PAKIRNI CENTER LENDAVA TRIMLINI	SLOVENIA	$176.1K	4
SANDOZ PHARMACEUTICAL TAIWAN CO.LTD	TAIWAN	$155.2K	4
SANDOZ (CHINA) PHARMACEUTICAL CO.,	CHINA	$150.0K	3
NOVARTIS TAIWAN CO LTD	TAIWAN	$150.0K	3
SANDOZ CHINA PHARMACEUTICAL CO LIMITED	CHINA	$150.0K	3

Sandoz Private Limited supplies Clopidogrel to 23 buyers globally. The largest buyer is LEK D.D (SLOVENIA), followed by SANDOZ(CHINA)PHARMACEUTICAL CO.,LTD (CHINA) and LEK D D (SLOVENIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Clopidogrel Formulations Does Sandoz Private Limited Export?

Product Description / Formulation	Value	Shipments
CLOPIDOGREL HCL FCT 75MG IN91 SH EU 04 MATERIAL NO. - 42024924	$550.0K	11
CLOPIDOGREL HCL FCT 75MG IN91 SH EU 04 M	$400.0K	8
CLOPIDOGREL SDZ 75MG 28FCT TW MATERIAL N	$283.0K	6
Material No.-44087964,CLOPIDOGREL HYSUL	$242.2K	5
Material No. - 44022751 CLOPIDOGREL SDZ75MG 28FCT TW	$195.2K	4
MATERIAL NO- 44087964 CLOPIDOGREL HYSUL75MG 14FCT CN	$166.7K	4
Material No. - 44087964, CLOPIDOGREL HYS	$150.0K	3
Material No. - 42024924 CLOPIDOGREL HCL	$150.0K	3
CLOPIDOGREL HYSUL 75MG 14FCT CN MATERIALNO-44087964	$150.0K	3
MATERIAL NO. - 42024924 CLOPIDOGREL HCLFCT 75MG IN91 SH EU 04PCS	$150.0K	3

Sandoz Private Limited exports 53 distinct Clopidogrel formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CLOPIDOGREL HCL FCT 75MG IN91 SH EU 04 MATERIAL NO. - 420249 with 11 shipments worth $550.0K.

How Does Sandoz Private Limited Compare to Nearest Clopidogrel Exporters?

Exporters ranked immediately above and below #9 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
8	AJANTA PHARMA LIMITED	$7.0M	140	18	$50.0K
14	INTAS PHARMACEUTICALS LIMITED	$5.3M	301	19	$17.6K
9	SANDOZ PRIVATE LIMITED ★	$5.3M	105	7	$50.0K
15	MICRO LABS LIMITED	$5.2M	217	20	$24.0K
10	MYLAN LABORATORIES LIMITED	$4.3M	86	3	$50.0K

Sandoz Private Limited ranks #9 among 416 Indian Clopidogrel exporters. Average shipment value of $50.0K compared to the market average of $320.2K. The closest competitors by value are AJANTA PHARMA LIMITED and INTAS PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Clopidogrel Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	576	9.5%
HYDERABAD ICD (INSNF6)	490	8.1%
HYDERABAD ICD	408	6.8%
SAHAR AIR CARGO ACC (INBOM4)	366	6.1%
SAHAR AIR	350	5.8%
JNPT/ NHAVA SHEVA SEA	295	4.9%
DELHI AIR CARGO ACC (INDEL4)	267	4.4%
DELHI AIR	256	4.2%

Geopolitical & Trade Policy Impact on Sandoz Private Limited's Clopidogrel Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Sandoz Private Limited. The escalation of conflicts in West Asia, particularly between Israel and Iran, has disrupted vital trade corridors such as the Red Sea and the Strait of Hormuz. These disruptions have led to increased shipping costs and extended transit times, impacting the timely delivery of pharmaceutical products. The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has warned that prolonged disruptions could result in potential losses of up to ₹5,000 crore for the industry. (timesofindia.indiatimes.com)

Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, creating opportunities for Indian exporters. Sandoz's established presence and compliance with international quality standards position it favorably to capitalize on this shift. However, the company must navigate the complexities of the European Union's Falsified Medicines Directive, which imposes stringent regulations to prevent counterfeit medicines from entering the supply chain. Adherence to these regulations is crucial for maintaining access to the lucrative EU market.

Sandoz Private Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Sandoz Private Limited. The company adheres to guidelines set forth by the U.S. Food and Drug Administration (FDA), the World Health Organization (WHO), and the European Union's Good Manufacturing Practices (EU GMP). Maintaining these certifications ensures the quality and safety of its products, facilitating access to global markets.

The evolving regulatory environment necessitates continuous investment in quality assurance and compliance. Sandoz's commitment to these standards not only mitigates the risk of regulatory actions but also enhances its reputation as a reliable supplier in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Clopidogrel shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Sandoz Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 105 individual customs records matching Sandoz Private Limited exporting Clopidogrel, covering 53 formulations to 7 countries via 23 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 137+ countries, 1,234+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Clopidogrel

Clopidogrel

Sandoz Private Limited — Clopidogrel Exporter Profile

Sandoz Private Limited — Clopidogrel Export Profile: Buyers & Destinations

Where Does Sandoz Private Limited Export Clopidogrel?

Who Are the Top Buyers of Clopidogrel from Sandoz Private Limited?

What Is India's Total Clopidogrel Export Value and How Much Does Sandoz Private Limited Contribute?

What Is the Average Shipment Value for Sandoz Private Limited's Clopidogrel Exports?

How Does Sandoz Private Limited Compare to Other Indian Clopidogrel Exporters?

What Clopidogrel Formulations Does Sandoz Private Limited Export?

How Does Sandoz Private Limited Compare to Nearest Clopidogrel Exporters?

Which Indian Ports Ship Clopidogrel Exports?

What Other Cardiovascular Products Does Sandoz Private Limited Export?

Geopolitical & Trade Policy Impact on Sandoz Private Limited's Clopidogrel Exports

Sandoz Private Limited — Regulatory Compliance & Quality Standards

About Sandoz Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Clopidogrel Export Data from Sandoz Private Limited

Clopidogrel Stats

Company Overview

Top Products by Sandoz Private Limited

Related Analysis

Need Detailed Export Data?

Data Source